The reported incidence of AKT activation varies from 26% in prostate cancer (Malik et al, 2002) to 66% in melanoma (Dhawan et al, 2002), and aerodigestive squamous cell carcinoma (Gupta et al, 2002). The gene discussed is AKT1; the disease is prostate carcinoma.